Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects

Quick Summary:

Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to its trial results, it has some pretty freaky side effects.

Unlike glucagon-like peptide-1 (GLP-1) receptors, the class of drugs to which Ozempic and Wegovy belong, CB1 receptors work on the brain and not the gut.

Though the drugs' areas of operations are different, some of their side effects are similar.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Noor Al-Sibai

Category: Technology

Markets: United States

Topics: Rx/Medicines Novo nordisk Side effects Mental health Neoscope Weight Loss

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-21 @ 11:30:32 (1 weeks ago)

News Timezone: GMT +8:00

News Source URL: futurism.com

Language: English

Article Length: 391 words

Reading Time: 3 minutes read

Sentences: 16 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Futurism

News ID: 22630941

View Article Analysis

About Futurism

Main Topics: Technology

Official Website: futurism.com

Year Established: 1997

Headquarters: United States

News Last Updated: 1 days ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #68

Publisher Details

Frequently Asked Questions